Magnetic nanoparticles could enhance the efficacy of cancer immunotherapy

NewsGuard 100/100 Score

Boosting the function of natural killer cells with magnetic nanoparticles could make cancer immunotherapy more efficient, according to a Northwestern Medicine study published in ACS Nano.

This method could unlock the potential to use natural killer (NK) cells on a variety of solid tumors, according to Dong-Hyun Kim, PhD, associate professor of Radiology in the Division of Basic and Translational Radiology Research and senior author of the study.

"People have had trouble applying NK cells to solid tumors," said Kim, who is also director of Biomaterials for Image-Guided Medicine (BIGMed) laboratory and a member of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University. "If we can provide an easy path to modulate NK cells, perhaps this can become a useful therapy."

Most cell-based immunotherapies target T-cells, part of the body's adaptive immune system. However, these chimeric antigen receptors (CAR) T-cell therapies come with a high price tag, long incubation period, and strong side effects.

On the other hand, NK cells are part of the body's innate immune system and quicker to respond to anything foreign. Many scientists have explored the possibility of NK cell immunotherapy, according to Kim, but that too has barriers.

It's pretty hard for these cells to penetrate inside the tumors which have thick barrier tissues."

Dong-Hyun Kim, PhD, Associate Professor, Radiology, Division of Basic and Translational Radiology Research, Northwestern University

Magnetically activated NK cells contacting cancer cells.

Methods to boost NK cell function using cytokines have largely fallen flat and are subject to some of the same problems as seen in CAR T-cell therapy — high cost and lengthy manufacturing time. However, Kim's previous work with nanoparticles inspired a different approach.

Kim and his collaborators designed a magnetic nano complex that binds with NK cells and when activated with an alternating magnetic field, exerts a force on the exterior of the cell, promoting the secretion of cytotoxic compounds. Testing this nano complex in animal models of hepatocellular carcinoma, the investigators found that magnetic activation increased the cancer-killing ability of NK cells when injected into solid tumors.

Further, these nanoparticles are easily visualized on magnetic resonance imaging, allowing for precise monitoring of NK cell distribution during and after injection.

"This creates a stronger NK cell, and can hopefully enhance the efficacy of the treatment," Kim said.

Taehoon Sim, PhD, a postdoctoral fellow in the Kim laboratory, was the lead author of the study.

This work was mainly supported by grants R01CA218659 and R01EB026207 from the National Cancer Institute and the National Institute of Biomedical Imaging and Bioengineering. This work was also supported by the Center for Translational Imaging and the Mouse Histology and Phenotyping Laboratory at Northwestern University.

Journal reference:

Sim, T., et al. (2021) Magneto-Activation and Magnetic Resonance Imaging of Natural Killer Cells Labeled with Magnetic Nanocomplexes for the Treatment of Solid Tumors. ACS Nano.


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Combo of targeted and immunotherapy may boost NSCLC treatment by overcoming immune resistance and enhancing anti-tumor activity